Signiosbio
signiosbio.com
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
MedGenome is a genomics diagnostics and research company that applies machine learning to South Asian genetic data. Founded in 2013 in Bengaluru, it runs one of the region's largest sequencing operations alongside a research arm serving pharmaceutical partners. Its datasets address populations underrepresented in global genomic references.
News
new Illumina StrataMap Spatial solution
Selected researchers gain no-cost access to an NGS-based spatial workflow that delivers single-cell resolution across one of the largest capture areas available
Read more
Report
MedGenome Appoints Industry Veterans Felix Olale, M.D., Ph.D., as CEO and Jennifer Rose as Chief Commercial Officer to Lead U.S. Expansion
Read more
Report
MedGenome to Exhibit Proprietary Sequencing and Informatics Solutions at the American Association for Cancer Research Annual Meeting
Read more
Report
MedGenome announces $50 million investment led by Novo Holdings
Novo's investment will strengthen MedGenome's scale beyond India and South Asia into Africa and the Middle-East and democratise access to genetic testing and personal healthcare across emerging markets.
Read more
Report
Pro access
Upgrade to see all 10 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.